Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.2%)
Apr 5 12:25 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Mar 27 16:20 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Mar 21 17:32 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.46%)
Feb 13 17:08 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nikko Asset Management Americas, Inc.(4.94%)
Feb 12 18:11 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”)(4.94%),Nikko Asset Management Co., Ltd. (“NAM”)(4.94%)
Feb 5 06:12 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(7.66%)
Jan 29 16:05 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.0%)
Jan 25 14:13 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.10%)
Jan 25 07:49 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Federated Hermes, Inc.(17.63%),Voting Shares Irrevocable Trust(17.63%), etc.
Jan 17 00:00 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer SASSINE ANDY
Dec 19, 2023 20:01 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Dec 19, 2023 20:01 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Kurata Lance
Dec 19, 2023 20:01 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kummerfeld Keith C
Dec 19, 2023 20:00 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Payne Joseph E
Dec 19, 2023 20:00 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Nov 3, 2023 16:30 ET
Arcturus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.27%)
Oct 10, 2023 11:20 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Oct 4, 2023 16:06 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Sep 5, 2023 16:05 ET
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer SASSINE ANDY
Aug 17, 2023 17:00 ET
No Data
No Data